Status: Recruiting
A Safety Study of IVMED-85 Ophthalmic Solution in Healthy Adults
The purpose of this trial is to determine the safety of IVMED-85 eye drops in healthy adult subjects. Participants will be assigned to either the active or vehicle eyedrop group. The participants will receive eye drops twice daily for 6 weeks. Participants will not know which eyedrop they are taking.
Participants needed: 36
Trial details
Phase: Phase 1Age: 18-49Biological sex: AllType: InterventionalSponsor: iVeena Delivery Systems, Inc.Updated: Feb 5, 2026Locations: 1
Eligibility criteria
Subjects who meet all the following inclusion criteria at Visit 1 will be eligib... [+10]
Participation in a clinical trial with the use of any investigational drug or tr... [+16]